Evidence map›Paper›PMID 42043330›Full record

ArticleChemMedChem2026

Allium-Derived Compounds Against Multidrug-Resistant Bacteria: Antibacterial Activity and Synergistic Effects.

Antonio Sorlózano-Puerto, Yariel Figueroa-Vega, Pablo Martín-Valenzuela, José Manuel de la Torre-Ramírez, Alberto Baños, José Gutiérrez-Fernández

Abstract read
In one paragraph

Article in ChemMedChem, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Antonio Sorlózano-PuertoDepartment of Microbiology, Faculty of Medicine, University of Granada and Instituto de Investigación Biosanitaria ibs.GRANADA, Granada, Spain.ORCID https://orcid.org/0000-0003-0249-2291
Yariel Figueroa-VegaDepartment of Microbiology, Faculty of Medicine, University of Granada and Instituto de Investigación Biosanitaria ibs.GRANADA, Granada, Spain.
Pablo Martín-ValenzuelaDepartment of Microbiology, Faculty of Medicine, University of Granada and Instituto de Investigación Biosanitaria ibs.GRANADA, Granada, Spain.
José Manuel de la Torre-RamírezDMC Research Center, Alhendín, Granada, Spain.
Alberto BañosDMC Research Center, Alhendín, Granada, Spain.
José Gutiérrez-FernándezDepartment of Microbiology, Faculty of Medicine, University of Granada and Instituto de Investigación Biosanitaria ibs.GRANADA, Granada, Spain.

Funding

University of Granada / CBUA
6 · The paper itself

Abstract

BACKGROUND AND

objectivesAntibiotic resistance is a major global health challenge, driven by misuse in medicine and agriculture and the scarcity of new drugs. Allium-derived organosulfur molecules have shown antimicrobial and synergistic effects with antibiotics. This study aimed to evaluate the in vitro antibacterial activity of four Allium-derived compounds and their potential synergy with clinical antibiotics against multidrug-resistant bacteria.

methodsA total of 330 multidrug-resistant clinical isolates were analyzed, including Gram-positive cocci and Gram-negative bacilli. Antibacterial activity of propyl-propane-thiosulfinate, propyl-propane-thiosulfonate (PTSO), butyl-butane-thiosulfinate, and butyl-butane-thiosulfonate was determined by broth microdilution. Synergy with conventional antibiotics was assessed in 24 representative isolates using the checkerboard method, with interactions classified by the fractional inhibitory concentration index.

resultsPTSO exhibited the highest activity, with MIC

conclusionPTSO demonstrated the most significant activity against multidrug-resistant Gram-positive bacteria, with limited impact on Gram-negative strains, and partial synergy with aminoglycosides suggests a potential role for combination therapy.

Indexed as

AlliumAnti-Bacterial AgentsDrug Resistance, Multiple, BacterialGram-Negative BacteriaGram-Positive BacteriaDose-Response Relationship, DrugDrug SynergismHumansMicrobial Sensitivity TestsMolecular StructureStructure-Activity RelationshipAnti-Bacterial Agentsalliumantibiotic resistancedrug synergismorganosulfur compounds

Identifiers

PMID42043330
PMCPMC13116028

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.